Treatment and outcome of fibrillary and immunotactoid GN
{"Image DocumentName": "Treatment and outcome of fibrillary and immunotactoid GN", "Image ImageDescription": "Fibrillary GN. N = 61. Immunotactoid GN. N = 14. Treatment. Corticosteroids \uf0b1 Cyclophosphamide. (crescentic GN) Lymphoproliferative disease. or plasma cell dyscrasia. (MGUS) Outcome. Poor response to. treatment. CR of NS : 10/12 (> 80%), parallel to hematologic. remission. Incidence of ESRD. 45 to 56% (median time : 24.4 months) 14% From Bridoux et al. (Kidney Int, 2002) and Rosenstock et al. (Kidney Int, 2003) BM - PR H\u00e9mopathies lympho\u00efdes et GN - CUEN Juin10.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}